Objectives: Typhoidal and non-typhoidal infection by Salmonella is a serious threat to human health. Ciprofloxacin is the last drug of choice to clear the infection. Ciprofloxacin, a gyrase inhibitor, kills bacteria by inducing chromosome fragmentation, SOS response and reactive oxygen species (ROS) in the bacterial cell. Curcumin, an active ingredient from turmeric, is a major dietary molecule among Asians and possesses medicinal properties. Our research aimed at investigating whether curcumin modulates the action of ciprofloxacin.
Introduction
Salmonella is a causative agent of salmonellosis, one of the major reasons for morbidity and mortality throughout the world. The successful treatment of typhoid patients is a challenge, especially in immunocompromised individuals. The emergence of multidrug-resistant strains further calls for alternative drugs against typhoid. 1 Ciprofloxacin is a promising alternative antibiotic because of its ability to penetrate into the macrophages 2 -4 and its ability to kill multidrug-resistant strains. 4 -6 However, in the past few years the emergence of ciprofloxacinresistant Salmonella strains has been reported. 7 -9 The efficacy of ciprofloxacin is attributed to its ability to affect various activities of bacterial DNA gyrase 10, 11 without affecting mammalian topoisomerases at a concentration ,150 mg/L. the bacterial cells. 26 The superoxide thus produced subsequently damages iron-sulphur clusters, leading to the formation of cytotoxic hydroxyl radicals via the Fenton reaction. ROS, produced by the host cells in response to microbial infection, may also contribute to bacterial death. Cell-penetrating iron chelators and hydroxyl radical quencher have been found to reduce the damage caused by bactericidal antibiotics. 25 It has also been demonstrated that antioxidants, like glutathione and ascorbic acid, protected the bacteria against ciprofloxacin action. 23 This argues against the consumption of antioxidants during antibiotic treatment.
In our study, we assessed the effect of curcumin, a dietary antioxidant, on Salmonella pathogenesis and its interference with the antimicrobial activity of ciprofloxacin in the murine model of typhoid fever. Curcumin possesses antioxidant 27 and anti-inflammatory properties. 28 The UV-induced SOS response was shown to be inhibited by curcumin. 29 The role of all these properties in rescuing Salmonella from the detrimental effects of ciprofloxacin was tested. We found that curcumin abrogated various cytotoxic effects of ciprofloxacin against Salmonella Typhi and Salmonella Typhimurium, giving them a survival advantage. Our study highlights the effect of diet on the outcome of typhoid disease and its treatment, especially considering the prevalence of typhoid in Asia, where consumption of curcumin is 0.03 -0.12 g/person/day. 30 
Materials and methods

Bacterial strains, medium and growth conditions
Salmonella Typhimurium strain 12023/14028 and Salmonella Typhi Ty2 were used as wild-type (WT) strains. All the strains were gifts from Professor M. Hensel (Institut fü r Klinische Mikrobiologie, Erlangen, Germany). The strains were grown at 378C in Luria broth (LB), with respective antibiotics. Curcumin (Sigma) and ciprofloxacin (Sigma) were added to the medium wherever required.
Eukaryotic cell lines and growth conditions
RAW 264.7 and U937 cells, gifts from Professor Anjali Karande (Department of Biochemistry, IISc, Bangalore, India), were grown in Dulbecco's modified minimum essential medium or RPMI 1640 supplemented with 10% fetal bovine serum at 378C and 5% CO 2 .
Intracellular survival assay
A total of 1.5×10 5 RAW 264.7 or U937 cells per well were seeded in 24-well plates. The U937 cells were stimulated with 10 ng/mL phorbol 12-myristate 13-acetate 2 days prior to infection. These cells were infected with Salmonella Typhimurium (RAW 264.7 cells) or Salmonella Typhi (U937 cells), in stationary phase, at a multiplicity of infection of 10 and the intracellular survival was assayed. 31 For the ciprofloxacin susceptibility assay, 0.5 mg/L ciprofloxacin was added along with 25 mg/L gentamicin. For the interferon g (IFNg)-related study, RAW 264.7 cells were pre-treated with IFNg for 22-24 h. The cells were lysed with Triton X-100 at different timepoints. The lysates were plated to determine the cfus.
Antibiotic susceptibility assay
Salmonella Typhimurium was grown at 378C for 12-16 h in LB. Overnight cultures were subcultured into fresh medium (1: 50) . After 2 h the cultures (optical density at 600 nm of 0.25 -0.4) were used for the determination of antibiotic susceptibility. Ciprofloxacin was added to a final concentration of 0.5 and 2 mg/L. The cultures were then incubated at 378C at 180 rpm. After 3 h the cultures were diluted and plated to estimate the percentage of survivors with respect to the initial pre-inocula. The bacteria were also observed with a confocal microscope to determine the change in the shape, if any. The bacteria with a length .5 mm were considered filamentous. The percentage of such bacteria in the population of bacteria was calculated for each experiment.
For the membrane potentiation assay the bacteria were treated with 0.5 and 2 mg/L ciprofloxacin for 2 h and were then incubated with 1 mg/L of bis-(1,3-dibutylbarbituric acid)-trimethine oxonol [DiBAC 4 (3); Invitrogen] for 10 min and washed twice with PBS. The samples were further analysed in an FACS scanner (BD Biosciences) to test for metabolically active bacteria.
Animal experiments
Animal experiments were carried out with prior approval from the Institutional Animal Ethics Committee (approval numberCAF/Ethics/189/2010), Indian Institute of Science, Bangalore. The guidelines stipulated by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and Forests, Government of India, New Delhi (registration number 48/1999/CPCSEA) were followed while carrying out all animal experiments. BALB/c mice, 6-7 weeks old (obtained from the Central Animal Facility, Indian Institute of Science, Bangalore), were maintained under specific pathogen-free conditions. All the procedures with mice were carried out according to institutionally approved protocols. Mice were infected intragastrically with 10 7 cfu of Salmonella Typhimurium for the organ infiltration study. Mice were either fed with 80 mg/kg body weight/day of curcumin for 4 days before or after infection. One set of mice were fed with curcumin 5 days pre-and post-infection. Ciprofloxacin treatment (50 mg/kg body weight every 12 h) was started 3 days post-infection. On the fifth day post-infection, liver, spleen, mesenteric lymph nodes and Peyer's patches were isolated under aseptic conditions, weighed and homogenized in a tissue homogenizer with 1 mL of PBS. The homogenate was plated at different dilutions. The number of cfu per gram weight of the organ was calculated.
Confocal microscopy RAW 264.7 and U937 cells, grown on coverslips, were infected with WT-green fluorescent protein (GFP) (Salmonella Typhimurium and Salmonella Typhi, respectively) as described in the intracellular survival assay protocol. The cells were fixed with 3.5% paraformaldehyde at different timepoints (24 h, IFNg; 8 h, ciprofloxacin). Extracellular bacteria were labelled with primary antibody against Salmonella (Salmonella polyflagellar antibody, Difco) followed by cy3 conjugated secondary antibody. Samples were observed under a confocal microscope (Carl Zeiss) and analysed for filamentous Salmonella as described previously. 32 The bacteria that had a length .5 mm were considered as filamentous and the percentage of filamentous bacteria per experiment was calculated.
Thymidine release assay
The assay was done as described previously. 33 Briefly, bacteria from an overnight culture were subcultured at a 1 : 50 ratio in LB containing 4 mCi/mL [methyl-3 H]thymidine. The cultures were incubated at 378C at 180 rpm for 3 h. The cells were washed three times with PBS (centrifugation at 7000 rpm). The washed cultures were resuspended in LB without [methyl- 3 H]thymidine. The cultures were either treated or untreated with ciprofloxacin (2 mg/L) for 4 h. The samples were processed to calculate the thymidine release. The fold increase in the percentage was calculated as follows: % thymidine released (treated)/% thymidine release (untreated).
TUNEL assay
The cells were treated as described for the thymidine release assay. The TUNEL assay was done as described previously 34 and as per the manufacturer's protocol (DeadEnd Fluorometric TUNEL System, Promega).
Bacterial RNA extraction and RT-PCR analysis RNA was isolated from the log-phase bacteria grown in LB in the presence and absence of curcumin and exposed or un-exposed to ciprofloxacin. cDNA was prepared from bacterial RNA using reverse primers of the ftsZ, umuC and 16s rRNA reverse transcription system in accordance with the manufacturer's protocol (Thermo Fischer). The cDNA thus obtained was stored at 2208C. cDNA was amplified (35 cycles or 20 cycles for 16S rRNA) using primers (ftsZ forward: tgaagaccgtgcggaagaag, ftsZ reverse: gatgcaaaggcacggatggt; umuC forward: cagggcaaagggtga tgt, umuC reverse: cgtaccgtgagagagcttcg; 16S rRNA forward: gatcatggctcagattgaacgctggcgg, 16S rRNA reverse: caccgctacacctggaat tatacccccctc) that amplify the intergenic region of the specific genes.
Immunoblot
The ciprofloxacin treatment of Salmonella Typhimurium was done as described for the antibiotic susceptibility assay. After 3 h of ciprofloxacin treatment the cells were lysed and processed for immunoblotting with affinity-purified anti-Escherichia coli FtsZ antibody 35 at 1 : 5000 dilution and anti-sera against E. coli Rrf (a kind gift from Professor Umesh Varshney, Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India).
RAW 264.7 cells treated with IFNg (20 U/mL, 12 h) and curcumin (10 mM), were infected with Salmonella Typhimurium. The cells were lysed and processed for immunoblotting with anti-ERK and p-ERK antibodies 2 h post-infection.
Determination of ROS
Measurement of extracellular H 2 O 2 by a phenol red assay
A method devised by Wautier et al. 36 was used with some modification. Infected RAW 264.7 cells were incubated in solution containing NaCl (0.14 M), potassium phosphate (0.01 M; pH 7.0), glucose (0.0055 M), phenol red (200 mg/L) and horseradish peroxidase (19 U/mL; Genei). After 8 h the medium obtained, after pelleting down the cells, was assayed in a spectrophotometer at 610 nm. Total protein from each well was estimated using the Bradford method and the data recorded as the amount of H 2 O 2 produced per milligram of total protein. A standard curve with H 2 O 2 concentrations ranging from 0 to 10 mg/L in phenol red solution was generated.
Nitroblue tetrazolium (NBT) reduction
Bacteria were treated as mentioned for the antibiotic susceptibility assay. The assay was done as described previously. 37 Briefly, 375 mL of NBT (1 mg/mL) was added to 75 mL of treated or untreated culture. This mixture was incubated for 30 min at 378C. The reaction was stopped by adding 75 mL of 0.1 N HCl. The tubes were centrifuged at 5000 rpm for 10 min. The blue colour of the aqueous phase (culture supernatant) was measured at 575 nm (ROS extracellular). The blue crystals in bacterial pellets were dissolved with 300 mL of DMSO followed by the addition of 300 mL of PBS and the optical density was determined at 575 nm (ROS intracellular).
ROS detection using luminol
Overnight cultures were inoculated into fresh LB (1: 50). After 2 h the cultures (optical density at 600 nm of 0.25 -0.4) were used for the determination of ROS. Ciprofloxacin was added at a concentration of 0.5 mg/L or 2 mg/L. The assay was done as described previously with some modifications. 37 Immediately, 0.1 mL of culture was incubated with 0.1 mL of luminol (500 mM) and 19 U/mL horseradish peroxidase. The light emission was measured by chemiluminescence using a luminometer (Turner Designs, Sunnyvale, CA, USA). ROS produced by infected RAW 264.7 cells treated with IFNg (20 IU/mL, 12 h pre-treatment) and ciprofloxacin (0.5 mg/L, 1 h post-treatment) were measured in a similar manner 1 h post-infection. The cells were infected as mentioned for the intracellular survival assay.
DNA cleavage assay
Individual subunits of E. coli DNA gyrase were purified and the holoenzyme reconstituted as described earlier. 38 E. coli DNA gyrase (100 nM) was incubated with 300 ng of supercoiled pUC18 plasmid and curcumin (1-5 mM) in a supercoiling reaction buffer (35 mM Tris-Cl, pH 7.4, 5 mM MgCl 2 , 25 mM potassium glutamate, 2 mM spermidine, 2 mM ATP, 50 mg/mL BSA, 90 mg of yeast tRNA and 5% glycerol) for 10 min at 48C followed by the addition of 2.5 mg/L of ciprofloxacin to each reaction. The reactions were shifted to 378C for 30 min followed by the addition of 0.1% SDS to terminate the reaction and the addition of 90 mg/mL proteinase K to digest the covalently bound protein. The incubation was continued for another 1 h followed by heat inactivation at 758C for 10 min. The reaction products were resolved by agarose (1.2%) gel electrophoresis and visualized on an UV trans-illuminator.
DNA binding assay
The mobility shift assay was done as described previously. 39 -41 A 240 bp DNA from pBR322 42 was PCR amplified using 32 P-labelled primer. E. coli DNA gyrase (100 nM) was incubated with 240 bp of DNA in the presence of increasing concentrations of curcumin for 15 min. The binding reactions were carried out in supercoiling reaction buffer. The DNA-bound complexes were resolved on 5% native PAGE and visualized using a PhosphorImager.
Statistical analysis
Each experiment was performed in triplicate and repeated a minimum of three times. Means+SEM were plotted. Data were analysed using Student's t-test or the Mann-Whitney U-test in GraphPad Prism software (version 5; GraphPad Software, La Jolla, CA, USA). The data were considered statistically significant for P values ≤0.05.
Results
Curcumin improved the survival of Salmonella Typhi and Salmonella Typhimurium treated with ciprofloxacin
Bactericidal antibiotics act by inducing the generation of ROS in bacterial cells. 25, 26 The oxidative radicals thus formed damage proteins, lipids and nucleic acids, poisoning the cells. 43 Iron chelators and antioxidants are known to attenuate the bactericidal effects of antibiotics. 25 It has been demonstrated that antioxidants protects E. coli from the lethal effects of norfloxacin, 24, 25 and probably ciprofloxacin. 23 In our study, we have tested the ability of curcumin, a commonly used antioxidant, to rescue Salmonella Typhi/Typhimurium from the bactericidal activity of Curcumin reduces the activity of ciprofloxacin 141 JAC ciprofloxacin. Intracellular proliferation and in vitro bacterial susceptibility assays were performed in the presence and absence of ciprofloxacin and curcumin. We found that curcumin increased the fold proliferation of both Salmonella Typhi and Salmonella Typhimurium by 2-to 4-fold in RAW 264.7 (murine macrophage like cell line) and U937 (human macrophage cell line) cell lines, respectively (Figure 1a) , and protected them from the detrimental effects of ciprofloxacin (0.5 mg/L; Figure 1a) . Hereafter, all the in vitro experiments were carried out with Salmonella Typhimurium.
An in vitro bacterial survival assay (based on the ability to form colonies on a drug-free agar plate following drug treatment) was performed to assess the ability of curcumin to protect Salmonella against the lethal action of ciprofloxacin (0.5 and 2 mg/L, the concentration of ciprofloxacin reached in the serum of humans/mice fed with recommended dose ciprofloxacin). 44 Curcumin prevents ciprofloxacin-mediated killing of bacteria as demonstrated by a cfu-based assay ( Figure 1b) .
The quinolone-treated bacteria, though unable to form colonies, are metabolically active. 45, 46 To assess for metabolically active bacteria, a membrane potentiation assay using DiBAC 4 (3) was performed. 47 The metabolically active bacteria are assumed to maintain an intact membrane potential through energy-dependent mechanisms and exclude dye, whereas the depolarized cells will take up the dye and fluoresce green. 47, 48 We found that the percentage of Salmonella Typhimurium positive for fluorescence greater than that of cells not exposed to ciprofloxacin was 2-to 4-fold less in curcumin-treated cells compared with curcumin-untreated cells (Figure 1c) . Thus, these results demonstrate that curcumin protects Salmonella against the bactericidal activity of ciprofloxacin.
The bactericidal action of ciprofloxacin was abrogated by curcumin in a mouse model of typhoid
The protective effect of curcumin against the microbicidal activity of ciprofloxacin was tested in the murine model of typhoid fever. BALB/c mice were fed with curcumin alone, ciprofloxacin alone, or both. The infected mice subjected to different treatment regimens were either dissected (on the fifth day) or monitored for survival. To determine the change in infection, if any, under different treatment conditions various organs of mice were isolated, homogenized and processed to calculate the bacterial burden. As shown in Figure 2 (a), cohorts of mice fed with curcumin alone had significantly high (2-to 7-fold) bacterial burden in all organs tested. Treatment of infected mice with ciprofloxacin reduced the bacterial burden in all organs tested (Figure 2a) . However, the bacterial burden was significantly high in organs of mice fed with curcumin and ciprofloxacin (Figure 2a) . A reduction in survival and body weight is the characteristic of Salmonella infection. When analysed for survival and alteration in body weight, we found that infected mice fed with both curcumin and ciprofloxacin showed significantly lower survival rates as compared with the mice fed with ciprofloxacin alone (Figure 2b ). Infected mice fed with curcumin had lower body weights than the infected mice not fed with curcumin ( Figure S1 , available as Supplementary data at JAC Online). Thus, the in vivo data further affirms that curcumin inhibits the microbicidal activity of ciprofloxacin, thus increasing the bacterial burden. We next analysed whether curcumin can rescue ciprofloxacin-mediated changes in bacteria.
Curcumin reduced ciprofloxacin-induced filamentation in Salmonella
Ciprofloxacin treatment is known to induce filamentation in a Gram-negative bacterium like E. coli. 49 We tested the ability of ciprofloxacin and curcumin to induce and inhibit filamentation in Salmonella, respectively. Two kinds of curcumin treatments were given. In one set, curcumin was present throughout the experiment [STM +Cur (Con)]; in the other set it was added along with ciprofloxacin [STM+ Cur (2 h)]. In both these cases, curcumin reduced the amount of ciprofloxacin-induced filamentation by 15% (Figure 3a) . The length of the ciprofloxacin-induced filaments was significantly shorter in bacteria grown in the presence of curcumin (Figure 3a) . The ciprofloxacin-induced filamentation was also observed in intracellular bacteria, Salmonella Typhimurium (RAW 264.7) or Salmonella Typhi (U937 cells), where the host cells were treated post-infection with ciprofloxacin (0.5 mg/L) ( Figure 3b ). The extent of ciprofloxacin-induced filamentation was reduced with treatment with curcumin by 30% -60% (30% Salmonella Typhimurium and 60% Salmonella Typhi) (Figure 3b ).
Curcumin reverses the downstream effects of ciprofloxacin
Ciprofloxacin is known to arrest the supercoiling reaction of DNA gyrase at the ternary complex state, inducing double-stranded breaks in bacterial chromosomes. 14, 15 Consequently, there is fragmentation of chromosomes 50 followed by the death of cells. ROS induced upon ciprofloxacin treatment 23 further increases the DNA damage. 51 The status of DNA damage was examined using various assays, i.e. by thymidine release and TUNEL assays. Both the experiments demonstrated that curcumin could curtail the ciprofloxacin-induced DNA damage ( Figure S2 , available as Supplementary data at JAC Online).
The cleaved DNA complexes lead to induction of the SOS response. 45, 52 Curcumin is known to inhibit induction of the SOS response. 29 Hence, expression of the umuC gene, a widely used marker for SOS induction, was assessed in bacterial cells treated with ciprofloxacin and curcumin. It was found that curcumin indeed suppressed the ciprofloxacin-induced expression of the umuC gene (Figure 4) , indicating inhibition of the SOS response. Induction of the SOS response further leads to the inhibition of cell division, making the bacteria filamentous. The evidence that the increased ftsZ gene dosage delayed the commencement of SOS-induced filamentation 53 prompted us to evaluate the levels of FtsZ protein in ciprofloxacin-exposed and curcumin-treated Salmonella Typhimurium. We found that curcumin-treated, ciprofloxacin-exposed Salmonella Typhimurium had elevated levels of FtsZ protein (Figure 4) . However, ftsZ mRNA did not show any significant difference (Figure 4) . Relatively high levels of FtsZ protein in curcumin-treated, ciprofloxacin-exposed cells can be correlated with inhibition of the SOS response by curcumin. Therefore, the reduction in the Figure 2 . Curcumin confers protection to Salmonella Typhimurium under in vivo conditions. (a) Bacterial burden in different organs of Salmonella Typhimurium-infected mice fed with curcumin and treated with ciprofloxacin. The mice were fed with curcumin under different regimens and were infected with Salmonella Typhimurium (10 7 bacteria/mice). One set of infected mice was treated with ciprofloxacin on the third and fourth days post-infection. All the mice were dissected on the fifth day post-infection and the bacterial burden in different organs was determined by plating the organ lysates on LB agar plates. Control, curcumin untreated; Oil, vehicle control (peanut/olive oil); Post, mice fed with curcumin (4 days) after infection; Pre, mice fed with curcumin (4 days) before infection; Simul, mice fed with curcumin immediately after infection; Pre+post, curcumin fed before (4 days) and after (4 days) infection. MLN, mesenteric lymph node. (b) Survival of Salmonella Typhimuriuminfected mice fed with curcumin and treated with ciprofloxacin. The mice were fed with curcumin under different regimens and were infected with Salmonella Typhimurium (10 8 bacteria/mice). One set of infected mice was treated with ciprofloxacin on the third and fourth days post-infection. The death of mice was recorded and the percentage survival plotted. STM, mice infected with Salmonella Typhimurium; STM+Cur, mice fed with curcumin before (4 days) and after (4 days) infection and infected with Salmonella Typhimurium; STM+CIP, mice infected with Salmonella Typhimurium and treated with ciprofloxacin on the third and fourth days post-infection; STM+Cur+CIP, Salmonella Typhimurium-infected mice fed with curcumin before (4 days) and after (4 days) infection and treated with ciprofloxacin on the third and fourth days post-infection. ***P, 0.001, **0.001≤P,0.01 and *0.01≤P, 0.05.
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Role of the antioxidant property of curcumin in protecting Salmonella against the action of ciprofloxacin
The inhibition of ciprofloxacin-mediated downstream effects by curcumin can be either due to curcumin's antioxidant property, its ability to reverse the ciprofloxacin-mediated gyrase inhibition, or its ability to prevent the access of gyrase to DNA by intercalating in the DNA, thereby preventing the access of ciprofloxacin to DNA-bound gyrase. We checked for the induction of ROS in Salmonella Typhimurium by ciprofloxacin and the ability of curcumin to suppress this induction. Chemiluminescence and the NBT reduction assay demonstrated a 1.5-to 3-fold induction of oxidative stress in bacteria on treatment with ciprofloxacin, whereas curcumin suppressed this induction (Figure 5a,b) . Ciprofloxacin also induced the production of ROS in both the infected and uninfected macrophages (RAW 264.7) (Figure 5c ) and curcumin suppressed this induction (Figure 5c ). When assessed for the possibility that curcumin can rescue ciprofloxacin-induced gyrase inhibition, we found that curcumin did not prevent the access of gyrase to DNA (Figure 5d ), nor does it prevent the ciprofloxacininduced cleavage of DNA by gyrase (Figure 5e ). This implies that the protection offered by curcumin to Salmonella against the bactericidal action of ciprofloxacin is a consequence of its antioxidant activity and ability to inhibit the SOS response rather than direct action at the arrested ternary complex, gyrase -DNA-ciprofloxacin.
Treatment of host macrophages with curcumin inhibits filamentation in Salmonella Typhimurium in IFNg-primed cells through the inhibition of reactive oxygen and nitrogen species ROS, produced by the host cells, restricts infection by pathogens. 32 There is an induction of ROS and MEK kinase cascade in the cells either primed with IFNg or infected with Salmonella.
32
This inhibits bacterial replication, inducing filamentation. 32 Curcumin acts as an antioxidant 27 and an inhibitor of the ERK pathway. 54 ,55 Thus, we tested the ability of curcumin to suppress ROS and MEK kinase cascade induced by Salmonella infection or IFNg. When tested for the intracellular proliferation of Salmonella Typhimurium in RAW 264.7 cells stimulated or unstimulated with IFNg (20 IU/mL, 20 -22 h), a 2-fold increase in bacterial proliferation was observed in the cells pre-treated with curcumin (10 mM) (Figure 6a ). Curcumin treatment also reduced (by 36%) the amount of IFNg-induced filamentation in Salmonella Typhimurium inside RAW 264.7 cells (Figure 6b ). To test whether curcumin has any effect on MEK kinase cascade, the activation of ERK was monitored in RAW 264.7 cells infected with Salmonella or induced with IFNg. It was observed that curcumin did not affect the activation of ERK at the concentration tested (Figure 7a ). However, curcumin decreased ROS production in RAW 264.7 cells primed or infected with IFNg and Salmonella, respectively (Figure 7b ). We can thus conclude that the antioxidant property of curcumin is important in reducing the ROS-induced filamentation in intracellular Salmonella Typhimurium. Curcumin also inhibited (by 2-fold) the induction of nitric oxide . in IFNg-primed and unprimed RAW 264.7 cells infected with Salmonella Typhimurium (Figure S3 , available as Supplementary data at JAC Online). The amount of inducible nitric oxide synthase was also less in cells (infected or induced with IFNg/lipopolysaccharide) pre-treated with curcumin compared with that present in untreated cells (data not shown). Thus, we speculate that both the anti-inflammatory and antioxidant property of curcumin might have a role in improving the survival of Salmonella Typhimurium inside the macrophages.
Discussion
Bactericidal antibiotics, like b-lactamases, aminoglycosides and quinolones possess a ROS-dependent killing mechanism. 24, 25 Gyrase-DNA complex 
Marathe et al.
Hence, the presence of antioxidants can interfere with the action of these antibiotics, rendering them less effective. We have tested the effect of curcumin, a well-known therapeutic agent with antioxidant properties, 27 on the bactericidal activity of ciprofloxacin, a member of the quinolone group of antibiotics. Ciprofloxacin is one of the few drugs that is effective against multidrug-resistant typhoid strains, 4 -6 though strains resistant to ciprofloxacin have been identified. 7 -9 It poisons bacteria by blocking the gyrase-mediated supercoiling reaction, inducing double-stranded DNA breaks. 14, 15 This leads to the inhibition of DNA synthesis, induction of the SOS response, fragmentation of chromosomes and generation of ROS. 50, 52, 56 Curcumin is consumed on a regular basis in Southeast Asia, 30 where the prevalence of typhoid is high. 57 Its intake during antibiotic therapy may interfere with the efficacy of antibiotics, delaying the recovery of typhoid patients. Our findings suggest that curcumin protected Salmonella against the ciprofloxacinmediated killing both in vitro and in vivo, thereby increasing the bacterial (Salmonella) burden in infected RAW 264.7 macrophages and reticuloendothelial organs of the infected mice. Our results are similar to those obtained by Moghaddam et al., 58 who showed that curcumin counteracted the antibacterial activity of nalidixic acid, belonging to the same class of antibiotics as ciprofloxacin, against Staphylococcus aureus. However, the authors did not see any interference of curcumin with the antibacterial activity of ciprofloxacin. 58 The presence of iron chelators like 2,2 ′ -dipyridyl reduces the hydroxyl radical formed due to the action of bactericidal antibiotics and rescues the bacteria from antibiotic-induced death. 25, 51 Curcumin, being a good iron chelator 59 and an antioxidant, can Curcumin reduces the activity of ciprofloxacin 149 JAC reduce the oxidative stress induced by bactericidal antibiotics (e.g. ciprofloxacin) and reverse their action, as is the case in our study. We can thus speculate that curcumin may reverse the oxidative stress induced by bactericidal antibiotics. However, when curcumin is used at a higher concentration it can act as a pro-oxidant, 60, 61 aggravating ROS production in antibiotic-treated bacterial cells.
Ciprofloxacin induced filamentation in extracellular as well as intracellular Salmonella. In the extracellular environment, the effect of ciprofloxacin is direct, whereas it can be direct or indirect on intracellular bacteria. Previous studies have illustrated that ciprofloxacin penetrates and accumulates inside the macrophage cells. 62, 63 According to Gurbay et al., 64 ciprofloxacin induced free radical formation in a time-and dose-dependent manner in liver microsomes, leading to lipid peroxidation. Thus, the induction of filamentation in intracellular bacteria might be due to the direct effect of ciprofloxacin on Salmonella through endogenous ROS, 18 -20 or the indirect effect of free radicals formed in ciprofloxacin-treated RAW 264.7 cells. We did see a reduction in the ciprofloxacin-induced oxidative stress in infected RAW 264.7 cells on curcumin treatment. This might contribute to the increased survival/replication of Salmonella inside the macrophages primed or unprimed with ciprofloxacin. Hartog et al. 63 demonstrated that ciprofloxacin (,1 mg/L) had a very mild effect on the physiology of intracellular bacteria. However, in our study we saw a decline in the Salmonella numbers at a concentration of 0.5 mg/L ciprofloxacin. The assay used by Hartog et al. 63 to check for an effect of ciprofloxacin on intracellular bacteria was based on the ability of the bacteria (with luciferase reporter plasmid) to emit light. However, we used cfus as a measure for the surviving bacteria against ciprofloxacin toxicity. The treatment in the Hartog et al. 63 study lasted for 1 h, whereas the treatment in our study lasted for 5 h. We too did not observe any cytotoxic effect of ciprofloxacin (0.5 mg/L) on intracellular bacteria up to 3 h (data not shown). The reduction in bacterial load was at the fifth and seventh hours of ciprofloxacin treatment.
Different assays demonstrated that curcumin inhibited ciprofloxacin-induced filamentation of Salmonella, generation of ROS, DNA damage and the SOS response (induction of the umuC gene). The induction in filamentation due to ciprofloxacin was a result of the inhibition of cell division. Almost all the cells treated with ciprofloxacin had FtsZ dispersed throughout the cytoplasm (data not shown). Curcumin did not affect the gyrase activity or accessibility of gyrase to DNA.
Our result of the inhibition of ciprofloxacin-induced filamentation is in contrast to that of Rai et al., 65 who showed that curcumin induces filamentation in Bacillus subtilis by inhibiting the GTPase activity of FtsZ. 65 This discrepancy might be due to the difference in the bacteria used (Gramnegative versus Gram-positive), concentration of curcumin (10 -20 versus 20 -100 mM) and the medium used for growing bacteria (LB, pH 7 versus LB + ascorbic acid, pH 6.5). Our experimental conditions were very close to the physiological conditions, while pH 6.5 (used by Rai et al. 65 ) was below the physiological pH. The concentration of curcumin used in our study was non-toxic to peritoneal macrophages, RAW 264.7, Intestine 407 and CaCo 2 cells for at least 24 h (data not shown). We observed that curcumin was not cytotoxic to Salmonella Typhimurium up to 80 mM ( 30 mg/L; data not shown), which is consistent with the results of Oda, 29 who showed that curcumin does not inhibit the growth of E. coli up to 30 mg/L.
The production of ROS is one of the innate immune mechanisms (type I response) that macrophages use against invading pathogens like Salmonella. The production of ROS is further stimulated by IFNg secreted by natural killer (NK) and T cells in response to Salmonella infection. This potentiates the killing of pathogens like Salmonella by macrophages. Inhibition of this induced inflammatory response and oxidative burst might be dangerous, as it can aggravate the disease. 32, 66 Our results of suppression of inflammatory response and oxidative stress induced on Salmonella infection (in IFNg-stimulated and unstimulated RAW 264.7 cells), and Adapala and Chan 67 provide evidence for the same. Apart from its effect on type I immune response, curcumin suppressed the action of ciprofloxacin against Salmonella (Typhimurium and Typhi), increasing their burden in host cells. These results caution us to be vigilant against the repercussions associated with the consumption of antioxidants like curcumin during antibiotic (ciprofloxacin or oxidative burst-inducing antibiotics) therapy against typhoid. This might interfere with the microbicidal activity of antibiotics, rendering them less effective.
